Role of appetite-regulating peptides in the pathophysiology of addiction: Implications for pharmacotherapy

CNS Drugs

Volumn 28, Issue 10, 2014, Pages 875-886

  Engel, Jörgen A ^a   Jerlhag, Elisabet ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1;

ADDICTION; ANIMAL; APPETITE; BRAIN; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REWARD;

ANIMALS; APPETITE; BEHAVIOR, ADDICTIVE; BRAIN; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 84933052758     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-014-0178-y     Document Type: Article

References (148)

1. Egecioglu E, Jerlhag E, Salome N, et al. Ghrelin increases intake of rewarding food in rodents. Addict Biol. 2010;15(3):304-11.
2. Zheng H, Lenard NR, Shin AC, et al. Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals. Int J Obes. 2009;33:S8-13.
3. Fulton S. Appetite and reward. Frontiers Neuroendocrinol. 2010;31(1):85-103.
4. Thiele TE, Stewart RB, Badia-Elder NE, et al. Overlapping peptide control of alcohol self-administration and feeding. Alcohol Clin Exp Res. 2004;28(2):288-94.
5. Morganstern I, Barson JR, Leibowitz SF. Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drug Abuse Rev. 2011;4(3):163-73.
6. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-60.
7. Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37(4):649-61.
8. Lu S, Guan JL, Wang QP, et al. Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus. Neurosci Lett. 2002;321(3):157-60.
9. Mondal MS, Date Y, Yamaguchi H, et al. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul Pept. 2005;126(1-2):55-9.
10. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86(12):5992.
11. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes. 2001;50(11):2540-7.
12. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141(11):4325-8.
13. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714-9.
14. Cummings DE, Frayo RS, Marmonier C, et al. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab. 2004;287(2):E297-304.
15. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908-13.
16. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, et al. Central ghrelin infusion regulates adipocyte glucose and lipid metabolism in rats. Int J Obes. 2006;30:S69.
17. van der Lely AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25(3):426-57.
18. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276(3):905-8.
19. Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006;9(3):381-8.
20. Hansson C, Haage D, Taube M, et al. Central administration of ghrelin alters emotional responses in rats: behavioural, electrophysiological and molecular evidence. Neuroscience. 2011;180:201-11.
21. Guan XM, Yu H, Palyha OC, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res. 1997;48(1):23-9.
22. Zigman JM, Jones JE, Lee CE, et al. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol. 2006;494(3):528-48.
23. Landgren S, Engel JA, Hyytia P, et al. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav Brain Res. 2011;221(1):182-8.
24. Larsson A, Engel JA. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev. 2004;27(8):713-20.
25. Di Chiara G, Imperato A. Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann N Y Acad Sci. 1986;473:367-81.
26. Weiss F, Lorang MT, Bloom FE, et al. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther. 1993;267(1):250-8.
27. Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol. 1989;40:191-225.
28. Engel JA, Fahlke C, Hulthe P, et al. Biochemical and behavioral evidence for an interaction between ethanol and calcium channel antagonists. J Neural Transm. 1988;74(3):181-93.
29. Soderpalm B, Ericson M. Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points. Curr Top Behav Neurosci. 2013;13:127-61.
30. Jerlhag E, Egecioglu E, Dickson SL, et al. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol. 2006;11(1):45-54.
31. Jerlhag E, Egecioglu E, Dickson SL, et al. Central administration of ghrelin stimulates parameters associated with reward. Nordic J Psychiatry. 2007;61(6):497-8.
32. Abizaid A, Liu ZW, Andrews ZB, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116(12):3229-39.
33. Jerlhag E, Janson AC, Waters S, et al. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLoS One. 2012;7(11):e49557.
34. Dickson SL, Hrabovszky E, Hansson C, et al. Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience. 2010;171(4):1180-6.
35. Banks WA, Tschop M, Robinson SM, et al. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302(2):822-7.
36. Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol. 2008;13(3-4):358-63.
37. Quarta D, Di Francesco C, Melotto S, et al. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem Int. 2009;54(2):89-94.
38. Jerlhag E, Egecioglu E, Dickson SL, et al. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict Biol. 2011;16(1):82-91.
39. Wellman PJ, Clifford PS, Rodriguez JA, et al. Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulation. Addict Biol. 2012;17(5):908-19.
40. Malik S, McGlone F, Bedrossian D, et al. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab. 2008;7(5):400-9.
41. Jerlhag E, Egecioglu E, Dickson SL, et al. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. Eur Neuropsychopharmacol. 2008;18(7):508-18.
42. Larsson A, Jerlhag E, Svensson L, et al. Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol? Alcohol. 2004;34(2-3):239-50.
43. Larsson A, Svensson L, Soderpalm B, et al. Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice. Alcohol. 2002;28(3):157-67.
44. Lof E, Olausson P, deBejczy A, et al. Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. Psychopharmacology (Berl). 2007;195(3):333-43.
45. Steensland P, Simms JA, Holgate J, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA. 2007;104(30):12518-23.
46. McKee SA, Harrison EL, O'Malley SS, et al. Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry. 2009;66(2):185-90.
47. Mitchell JM, Teague CH, Kayser AS, et al. Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology (Berl). 2012;223(3):299-306.
48. Skibicka KP, Shirazi RH, Hansson C, et al. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward. Endocrinology. 2012;153(3):1194-205.
49. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18(3):247-91.
50. Hansson C, Shirazi RH, Naslund J, et al. Ghrelin influences novelty seeking behavior in rodents and men. PLoS One. 2012;7(12):e50409.
51. Carroll ME, France CP, Meisch RA. Food deprivation increases oral and intravenous drug intake in rats. Science. 1979;205(4403):319-21.
52. Carroll ME, Lac ST. Dietary additives and the acquisition of cocaine self-administration in rats. Psychopharmacology. 1998;137(1):81-9.
53. Wolfe WL, Maisto SA. The relationship between eating disorders and substance use: moving beyond co-prevalence research. Clin Psychol Rev. 2000;20(5):617-31.
54. Thiele TE, Navarro M, Sparta DR, et al. Alcoholism and obesity: overlapping neuropeptide pathways? Neuropeptides. 2003;37(6):321-37.
55. Jerlhag E, Egecioglu E, Landgren S, et al. Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci USA. 2009;106(27):11318-23.
56. Landgren S, Simms JA, Hyytia P, et al. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addict Biol. 2012;17(1):86-94.
57. Bahi A, Tolle V, Fehrentz JA, et al. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. Peptides. 2013;43:48-55.
58. Kaur S, Ryabinin AE. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res. 2010;34(9):1525-34.
59. Suchankova P, Steensland P, Fredriksson I, et al. Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLoS One. 2013;8(8):e71284.
60. Jerlhag E, Landgren S, Egecioglu E, et al. The alcohol-induced locomotor stimulation and accumbal dopamine release is suppressed in ghrelin knockout mice. Alcohol. 2011;45(4):341-7.
61. Lyons AM, Lowery EG, Sparta DR, et al. Effects of food availability and administration of orexigenic and anorectic agents on elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res. 2008;32(11):1962-8.
62. Jerlhag E, Ivanoff L, Vater A et al. Peripherally circulating ghrelin does not mediate alcohol-induced reward and alcohol intake in rodents. ACER. 2013 (in press).
63. Jiang H, Betancourt L, Smith RG. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol. 2006;20(8):1772-85.
64. Kern A, Albarran-Zeckler R, Walsh HE, et al. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron. 2012;73(2):317-32.
65. Holst B, Cygankiewicz A, Jensen TH, et al. High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol Endocrinol. 2003;17(11):2201-10.
66. Cruz MT, Herman MA, Cote DM, et al. Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala. Neuropsychopharmacology. 2013;38(2):364-75.
67. Hansson C, Alvarez-Crespo M, Taube M, et al. Influence of ghrelin on the central serotonergic signaling system in mice. Neuropharmacology. 2014;79:498-505.
68. Landgren S, Simms JA, Thelle DS, et al. The ghrelin signalling system is involved in the consumption of sweets. PLoS One. 2011;6(3):e18170.
69. Calissendorff J, Danielsson O, Brismar K, et al. Inhibitory effect of alcohol on ghrelin secretion in normal man. Eur J Endocrinol. 2005;152(5):743-7.
70. Calissendorff J, Danielsson O, Brismar K, et al. Alcohol ingestion does not affect serum levels of peptide YY but decreases both total and octanoylated ghrelin levels in healthy subjects. Metab Clin Exp. 2006;55(12):1625-9.
71. Zimmermann US, Buchmann A, Steffin B, et al. Alcohol administration acutely inhibits ghrelin secretion in an experiment involving psychosocial stress. Addict Biol. 2007;12(1):17-21.
72. Calissendorff J, Gustafsson T, Holst JJ, et al. Alcohol intake and its effect on some appetite-regulating hormones in man: influence of gastroprotection with sucralfate. Endocr Res. 2012;37(3):154-62.
73. Leggio L, Schwandt ML, Oot EN, et al. Fasting-induced increase in plasma ghrelin is blunted by intravenous alcohol administration: a within-subject placebo-controlled study. Psychoneuroendocrinology. 2013;38(12):3085-91.
74. Addolorato G, Capristo E, Leggio L, et al. Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. Alcohol Clin Exp Res. 2006;30(11):1933-7.
75. Badaoui A, De Saeger C, Duchemin J, et al. Alcohol dependence is associated with reduced plasma and fundic ghrelin levels. Eur J Clin Invest. 2008;38(6):397-403.
76. Kraus T, Schanze A, Groschl M, et al. Ghrelin levels are increased in alcoholism. Alcohol Clin Exp Res. 2005;29(12):2154-7.
77. Szulc M, Mikolajczak PL, Geppert B, et al. Ethanol affects acylated and total ghrelin levels in peripheral blood of alcohol-dependent rats. Addict Biol. 2013;18(4):689-701.
78. Kim DJ, Yoon SJ, Choi B, et al. Increased fasting plasma ghrelin levels during alcohol abstinence. Alcohol Alcohol. 2005;40(1):76-9.
79. Wurst FM, Graf I, Ehrenthal HD, et al. Gender differences for ghrelin levels in alcohol-dependent patients and differences between alcoholics and healthy controls. Alcohol Clin Exp Res. 2007;31(12):2006-11.
80. Koopmann A, von der Goltz C, Grosshans M, et al. The association of the appetitive peptide acetylated ghrelin with alcohol craving in early abstinent alcohol dependent individuals. Psychoneuroendocrinology. 2012;37(7):980-6.
81. Leggio L, Ferrulli A, Cardone S, et al. Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict Biol. 2012;17(2):452-64.
82. Leggio L, Zywiak WH, Fricchione SR et al., Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. Biol Psychiatry. 2014.
83. Landgren S, Jerlhag E, Zetterberg H, et al. Association of pro-ghrelin and GHS-R1A gene polymorphisms and haplotypes with heavy alcohol use and body mass. Alcohol Clin Exp Res. 2008;32(12):2054-61.
84. Landgren S, Jerlhag E, Hallman J, et al. Genetic variation of the ghrelin signaling system in females with severe alcohol dependence. Alcohol Clin Exp Res. 2010;34(9):1519-24.
85. Landgren S, Berglund K, Jerlhag E, et al. Reward-related genes and personality traits in alcohol-dependent individuals: a pilot case control study. Neuropsychobiology. 2011;64(1):38-46.
86. Wellman PJ, Davis KW, Nation JR. Augmentation of cocaine hyperactivity in rats by systemic ghrelin. Regul Pept. 2005;125(1-3):151-4.
87. Davis KW, Wellman PJ, Clifford PS. Augmented cocaine conditioned place preference in rats pretreated with systemic ghrelin. Regul Pept. 2007;140(3):148-52.
88. Tessari M, Catalano A, Pellitteri M, et al. Correlation between serum ghrelin levels and cocaine-seeking behaviour triggered by cocaine-associated conditioned stimuli in rats. Addict Biol. 2007;12(1):22-9.
89. Jerlhag E, Egecioglu E, Dickson SL, et al. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl). 2010;211(4):415-22.
90. Clifford PS, Rodriguez J, Schul D, et al. Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors. Addict Biol. 2012;17(6):956-63.
91. Abizaid A, Mineur YS, Roth RH, et al. Reduced locomotor responses to cocaine in ghrelin-deficient mice. Neuroscience. 2011;192:500-6.
92. Gualillo O, Caminos JE, Nogueiras R, et al. Effect of food restriction on ghrelin in normal-cycling female rats and in pregnancy. Obes Res. 2002;10(7):682-7.
93. Jerlhag E, Engel JA. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend. 2011;117(2-3):126-31.
94. Wellman PJ, Clifford PS, Rodriguez J, et al. Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats. Regul Pept. 2011;172(1-3):77-80.
95. Suchankova P, Jerlhag E, Jayaram-Lindstrom N, et al. Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence. PLoS One. 2013;8(4):e61242.
96. Novak U, Wilks A, Buell G, et al. Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem. 1987;164(3):553-8.
97. Alvarez E, Roncero I, Chowen JA, et al. Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem. 1996;66(3):920-7.
98. Brubaker PL, Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol. 2003;81(11):1005-12.
99. Hayes MR, Skibicka KP, Grill HJ. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology. 2008;149(8):4059-68.
100. Langhans W. Anorexia of infection: current prospects. Nutrition. 2000;16(10):996-1005.
101. Naslund E, Schmidt PT, Hellstrom PM. Gut peptide hormones: importance for food intake. Scand J Gastroenterol. 2005;40(3):250-8.
102. Tang-Christensen M, Larsen PJ, Goke R, et al. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol. 1996;271(4 Pt 2):R848-56.
103. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996;379(6560):69-72.
104. Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987;2(8571):1300-4.
105. Holst JJ, Seino Y. GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes. Diabetes Res Clin Pract. 2009;85(1):1-3.
106. Matsuyama T, Komatsu R, Namba M, et al. Glucagon-like peptide-1 (7-36 amide): a potent glucagonostatic and insulinotropic hormone. Diabetes Res Clin Pract. 1988;5(4):281-4.
107. Gutniak M, Orskov C, Holst JJ, et al. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med. 1992;326(20):1316-22.
108. Shughrue PJ, Lane MV, Merchenthaler I. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology. 1996;137(11):5159-62.
109. Hayes MR, Bradley L, Grill HJ. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology. 2009;150(6):2654-9.
110. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999;403(2):261-80.
111. Alhadeff AL, Rupprecht LE, Hayes MR. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology. 2012;153(2):647-58.
112. Egecioglu E, Steensland P, Fredriksson I, et al. The glucagon-like peptide 1 analogue exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology. 2013;38(8):1259-70.
113. Shirazi RH, Dickson SL, Skibicka KP. Gut peptide GLP-1 and its analogue, exendin-4, decrease alcohol intake and reward. PLoS One. 2013;8(4):e61965.
114. Davis JF, Schurdak JD, Magrisso IJ, et al. Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats. Biol Psychiatry. 2012;72(5):354-60.
115. Erreger K, Davis AR, Poe AM, et al. Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav. 2012;106(4):574-8.
116. Graham DL, Erreger K, Galli A, et al. GLP-1 analog attenuates cocaine reward. Mol Psychiatry. 2013;18(9):961-2.
117. Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS One. 2013;8(7):e69010.
118. Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 analogue exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. PLoS One. 2013;8(10):e77284.
119. Blednov YA, Walker D, Harris RA. Blockade of the leptin-sensitive pathway markedly reduces alcohol consumption in mice. Alcohol Clin Exp Res. 2004;28(11):1683-92.
120. Kiefer F, Jahn H, Wolf K, et al. Free-choice alcohol consumption in mice after application of the appetite regulating peptide leptin. Alcohol Clin Exp Res. 2001;25(5):787-9.
121. Kiefer F, Jahn H, Otte C, et al. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res. 2005;39(5):545-51.
122. Nicolas JM, Fernandez-Sola J, Fatjo F, et al. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res. 2001;25(1):83-8.
123. Obradovic T, Meadows GG. Chronic ethanol consumption increases plasma leptin levels and alters leptin receptors in the hypothalamus and the perigonadal fat of C57BL/6 mice. Alcohol Clin Exp Res. 2002;26(2):255-62.
124. Lawrence AJ, Cowen MS, Yang HJ, et al. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol. 2006;148(6):752-9.
125. Richards JK, Simms JA, Steensland P, et al. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl). 2008;199(1):109-17.
126. Hamlin AS, Newby J, McNally GP. The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking. Neuroscience. 2007;146(2):525-36.
127. Brown RM, Lawrence AJ. Ascending orexinergic pathways and alcohol-seeking. Curr Opin Neurobiol. 2013;23(4):467-72.
128. Boutrel B, Kenny PJ, Specio SE, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA. 2005;102(52):19168-73.
129. Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005;437(7058):556-9.
130. Smith RJ, Aston-Jones G. Orexin/hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci. 2012;35(5):798-804.
131. von der Goltz C, Koopmann A, Dinter C, et al. Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology. 2010;35(4):570-7.
132. Borgland SL, Taha SA, Sarti F, et al. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron. 2006;49(4):589-601.
133. Leshan RL, Opland DM, Louis GW, et al. Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J Neurosci. 2010;30(16):5713-23.
134. Opland DM, Leinninger GM, Myers MG Jr. Modulation of the mesolimbic dopamine system by leptin. Brain Res. 2010;1350:65-70.
135. Thiele TE, Marsh DJ, Ste Marie L, et al. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 1998;396(6709):366-9.
136. Thorsell A, Rimondini R, Heilig M. Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett. 2002;332(1):1-4.
137. Rimondini R, Thorsell A, Heilig M. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci Lett. 2005;375(2):129-33.
138. Thorsell A, Repunte-Canonigo V, O'Dell LE, et al. Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain. 2007;130(Pt 5):1330-7.
139. Cippitelli A, Damadzic R, Hansson AC, et al. Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology (Berl). 2010;208(3):417-26.
140. Hillemacher T, Weinland C, Heberlein A, et al. Increased levels of adiponectin and resistin in alcohol dependence-possible link to craving. Drug Alcohol Depend. 2009;99(1-3):333-7.
141. Kulkosky PJ. Effect of cholecystokinin octapeptide on ethanol intake in the rat. Alcohol. 1984;1(2):125-8.
142. Toth P, Shaw C, Perlanski E, et al. Cholecystokinin octapeptide reduces ethanol intake in food- and water-sated rats. Pharmacol Biochem Behav. 1990;35(2):493-5.
143. Kulkosky PJ, Clayborne YJ, Sandoval SL. Cholecystokinin and bombesin inhibit ethanol and food intake in rats selectively bred for ethanol sensitivity. Alcohol Clin Exp Res. 1993;17(3):545-51.
144. Crespi F. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats. Methods Find Exp Clin Pharmacol. 1998;20(8):679-97.
145. Lewis MJ, Johnson DF, Waldman D, et al. Galanin microinjection in the third ventricle increases voluntary ethanol intake. Alcohol Clin Exp Res. 2004;28(12):1822-8.
146. Rada P, Avena NM, Leibowitz SF, et al. Ethanol intake is increased by injection of galanin in the paraventricular nucleus and reduced by a galanin antagonist. Alcohol. 2004;33(2):91-7.
147. Edwards S, Kenna GA, Swift RM, et al. Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des. 2011;17(14):1323-32.
148. Rodriguez FD, Covenas R. Targeting opioid and neurokinin-1 receptors to treat alcoholism. Curr Med Chem. 2011;18(28):4321-34.